ARJUNIN is a comprehensive cardioprotective. ARJUNIN has antianginal, hypolipidemic and antioxidant action. In double blind placebo controlled trial, the main ingredient of ARJUNIN i.e. Terminalia Arjuna exhibited antianginal effects similar to that of isosorbide mononitrate. Boerhaavia diffusa is anti-hyperlipidemic,Nardostachys jatamansi is anti-lipidperoxidative. ARJUNIN exhibits cardioprotective activity by virtue of its hypolipidemic, diuretic, anxiolytic and antioxidant properties.
ARJUNIN is a comprehensive cardioprotective. Arjunin is supportive therapy in patients at risk of heart problems.